ID

14228

Descripción

Study of the Effect of SR57667B in Patients With Alzheimer's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00285025

Link

https://clinicaltrials.gov/show/NCT00285025

Palabras clave

Versiones (1)
  1. 5/4/16 5/4/16 -
Subido en

5 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Alzheimer Disease NCT00285025

Inglés

Eligibility Alzheimer Disease NCT00285025

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male / female outpatients.
Descripción

gender outpatients

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0029921
age > 50 years at screening.
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
dementia of alzheimer’s type (dsm-iv 290.0) according to dsm-iv criteria, probable ad according to nincds-adrda criteria, mini-mental state examination score > 12 and < 26.
Descripción

dementia of alzheimers type; mini mental state examination score

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0236649
UMLS CUI [2]
C2960235
untreated or treated for a minimum of 6 months before randomization with a stable dose of the cholinesterase inhibitors
Descripción

therapy cholinesterase inhibitors

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0008425
generally healthy and ambulatory or ambulatory-aided (i.e., walker or cane).
Descripción

Health Status; ambulatory status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018759
UMLS CUI [2]
C1550332
presence of a reliable caregiver.
Descripción

caregiver

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085537
patient, identified caregiver and, if applicable, patient surrogate (primary relative, legal guardian, medical proxy) have given their informed written consent and are capable of following study procedures
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
any cause of dementia not due to alzheimer’s disease, delusions, delirium, psychosis, depression, or other significant psychiatric disorder.
Descripción

dementia; alzheimers disease; delusions; psychosis; depression; psychiatric disorder

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0497327
UMLS CUI [2]
C0002395
UMLS CUI [3]
C0011253
UMLS CUI [4]
C0033975
UMLS CUI [5]
C0011570
UMLS CUI [6]
C0004936
treatment with any registered or putative cognitive enhancer or disease modifier other than donepezil, rivastigmine or galantamine.
Descripción

donepezil; rivastigmine; galantamine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0527316
UMLS CUI [2]
C0649350
UMLS CUI [3]
C0016967
females who are pregnant or breast-feeding. females of child bearing potential (premenopausal female biologically capable of becoming pregnant) must have a confirmed negative serum b–hcg pregnancy test at the screening visit, and must use an acceptable method of birth control.
Descripción

pregnancy; lactating; premenopausal; negative pregnancy test

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0232969
UMLS CUI [4]
C0427780
severe or unstable cardiovascular, respiratory, renal, hematological, endocrinological, neurological or other somatic disease.
Descripción

comorbidity cardiovascular disease respiratory disease hematological disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0007222
UMLS CUI [1,3]
C0035204
UMLS CUI [1,4]
C0018939
use of cyp3a4 strong inhibitors
Descripción

cyp3a4 inhibitor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3830624
evidence (detected by history, physical examination and / or laboratory / ecg tests) of any clinically significant or unstable medical disorder that could interfere with the subject's participation in the clinical trial; interfere with the absorption, metabolism or excretion of the study medication; or interfere with the evaluation of the study drug. alterations of laboratory tests or ecg findings of potential clinical significance.
Descripción

Compliance behavior Limited Comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
Volver a la parte superior de la página

Similar models

Eligibility Alzheimer Disease NCT00285025

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
gender outpatients
Item
male / female outpatients.
boolean
C0079399 (UMLS CUI [1,1])
C0029921 (UMLS CUI [1,2])
age
Item
age > 50 years at screening.
boolean
C0001779 (UMLS CUI [1])
dementia of alzheimers type; mini mental state examination score
Item
dementia of alzheimer’s type (dsm-iv 290.0) according to dsm-iv criteria, probable ad according to nincds-adrda criteria, mini-mental state examination score > 12 and < 26.
boolean
C0236649 (UMLS CUI [1])
C2960235 (UMLS CUI [2])
therapy cholinesterase inhibitors
Item
untreated or treated for a minimum of 6 months before randomization with a stable dose of the cholinesterase inhibitors
boolean
C0087111 (UMLS CUI [1,1])
C0008425 (UMLS CUI [1,2])
Health Status; ambulatory status
Item
generally healthy and ambulatory or ambulatory-aided (i.e., walker or cane).
boolean
C0018759 (UMLS CUI [1])
C1550332 (UMLS CUI [2])
caregiver
Item
presence of a reliable caregiver.
boolean
C0085537 (UMLS CUI [1])
informed consent
Item
patient, identified caregiver and, if applicable, patient surrogate (primary relative, legal guardian, medical proxy) have given their informed written consent and are capable of following study procedures
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
dementia; alzheimers disease; delusions; psychosis; depression; psychiatric disorder
Item
any cause of dementia not due to alzheimer’s disease, delusions, delirium, psychosis, depression, or other significant psychiatric disorder.
boolean
C0497327 (UMLS CUI [1])
C0002395 (UMLS CUI [2])
C0011253 (UMLS CUI [3])
C0033975 (UMLS CUI [4])
C0011570 (UMLS CUI [5])
C0004936 (UMLS CUI [6])
donepezil; rivastigmine; galantamine
Item
treatment with any registered or putative cognitive enhancer or disease modifier other than donepezil, rivastigmine or galantamine.
boolean
C0527316 (UMLS CUI [1])
C0649350 (UMLS CUI [2])
C0016967 (UMLS CUI [3])
pregnancy; lactating; premenopausal; negative pregnancy test
Item
females who are pregnant or breast-feeding. females of child bearing potential (premenopausal female biologically capable of becoming pregnant) must have a confirmed negative serum b–hcg pregnancy test at the screening visit, and must use an acceptable method of birth control.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0232969 (UMLS CUI [3])
C0427780 (UMLS CUI [4])
comorbidity cardiovascular disease respiratory disease hematological disease
Item
severe or unstable cardiovascular, respiratory, renal, hematological, endocrinological, neurological or other somatic disease.
boolean
C0009488 (UMLS CUI [1,1])
C0007222 (UMLS CUI [1,2])
C0035204 (UMLS CUI [1,3])
C0018939 (UMLS CUI [1,4])
cyp3a4 inhibitor
Item
use of cyp3a4 strong inhibitors
boolean
C3830624 (UMLS CUI [1])
Compliance behavior Limited Comorbidity
Item
evidence (detected by history, physical examination and / or laboratory / ecg tests) of any clinically significant or unstable medical disorder that could interfere with the subject's participation in the clinical trial; interfere with the absorption, metabolism or excretion of the study medication; or interfere with the evaluation of the study drug. alterations of laboratory tests or ecg findings of potential clinical significance.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial